Cochrane Abstracts
Dopamine agents for hepatic encephalopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dopamine Agents for Hepatic Encephalopathy." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436239/1/Dopamine_agents_for_hepatic_encephalopathy.
Dopamine agents for hepatic encephalopathy. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436239/1/Dopamine_agents_for_hepatic_encephalopathy. Accessed February 25, 2026.
Dopamine agents for hepatic encephalopathy. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436239/1/Dopamine_agents_for_hepatic_encephalopathy
Dopamine Agents for Hepatic Encephalopathy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436239/1/Dopamine_agents_for_hepatic_encephalopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dopamine agents for hepatic encephalopathy
ID - 436239
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436239/1/Dopamine_agents_for_hepatic_encephalopathy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
